IRIS
BITTONI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.679
EU - Europa 1.601
AS - Asia 1.409
SA - Sud America 358
AF - Africa 127
Continente sconosciuto - Info sul continente non disponibili 92
OC - Oceania 1
Totale 7.267
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.616
SG - Singapore 530
IT - Italia 334
BR - Brasile 291
CN - Cina 265
VN - Vietnam 252
RU - Federazione Russa 226
UA - Ucraina 202
SE - Svezia 168
DE - Germania 160
IE - Irlanda 119
TR - Turchia 104
FI - Finlandia 88
FR - Francia 81
DK - Danimarca 72
HK - Hong Kong 72
GB - Regno Unito 68
CI - Costa d'Avorio 60
IN - India 46
KR - Corea 40
NL - Olanda 32
BD - Bangladesh 29
CA - Canada 28
MA - Marocco 27
MX - Messico 23
JP - Giappone 21
AR - Argentina 18
ZA - Sudafrica 17
EC - Ecuador 15
CO - Colombia 14
ES - Italia 13
PL - Polonia 11
IQ - Iraq 9
BE - Belgio 8
ID - Indonesia 7
DZ - Algeria 6
MY - Malesia 6
CL - Cile 5
UY - Uruguay 5
VE - Venezuela 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
KE - Kenya 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SC - Seychelles 3
TN - Tunisia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BO - Bolivia 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
LT - Lituania 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
RO - Romania 2
TW - Taiwan 2
AO - Angola 1
AU - Australia 1
BY - Bielorussia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
QA - Qatar 1
Totale 7.178
Salva come PNG Salva come JPEG
Città #
Ashburn 674
Singapore 331
Chandler 286
Jacksonville 215
Fairfield 210
San Jose 189
Wilmington 135
Dallas 124
Boardman 119
Dublin 118
New York 114
Woodbridge 103
Council Bluffs 102
Ann Arbor 95
Seattle 94
Houston 93
Des Moines 76
Beijing 73
Cambridge 72
Ho Chi Minh City 70
Centro 67
Hanoi 66
Hong Kong 66
Abidjan 60
Los Angeles 56
Moscow 49
The Dalles 49
Lawrence 47
Munich 47
Princeton 47
San Mateo 47
Lauterbourg 37
Turin 34
Turku 33
Orem 26
Milan 25
Buffalo 20
Santa Clara 19
Tokyo 19
London 18
San Diego 18
São Paulo 18
Helsinki 17
Chicago 16
Hefei 16
Atlanta 15
Frankfurt am Main 15
Chennai 14
Amsterdam 13
Brooklyn 13
Johannesburg 13
Da Nang 12
Montreal 12
Stockholm 12
Haiphong 11
Pune 11
Rome 11
Rio de Janeiro 10
Warsaw 9
Brussels 8
Curitiba 8
Denver 8
Guayaquil 8
Poplar 8
Brasília 7
Columbus 7
Fortaleza 7
Guangzhou 7
Manchester 7
Mexico City 7
Miano 7
Paris 7
San Francisco 7
St Petersburg 7
Washington 7
Wuhan 7
Wuxi 7
Belo Horizonte 6
Biên Hòa 6
Cagliari 6
Miami 6
Porto Alegre 6
Bogotá 5
Montevideo 5
Santiago 5
Bến Tre 4
City of London 4
Dhaka 4
Falls Church 4
Florence 4
Izmir 4
Mumbai 4
Nanjing 4
New Bedfont 4
Nuremberg 4
Olomouc 4
Prescot 4
Quito 4
Salt Lake City 4
Shanghai 4
Totale 4.617
Salva come PNG Salva come JPEG
Nome #
Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy 223
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 209
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy 204
The role of Aspirin as antitumoral agent for heavily pre-treated metastatic colorectal cancer patients receiving capecitabine monotherapy. BMC Cancer 197
The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan and cetuximab. 195
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 195
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. 195
Optimal management of resected gastric cancer 189
Lgr5 expression, cancer stem cells and pancreatic cancer: Results from biological and computational analyses 186
The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy 175
HER family receptor expression and prognosis in pancreatic cancer 169
KRAS: To be or not to be targeted? Biologic and computational analyses in pancreatic adenocarcinoma 169
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 169
Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New 164
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 164
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab. 163
KRAS mutation status is associated with specific pattern of genes expression in pancreatic adenocarcinoma 162
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients. 158
CANCER STEM CELL GENETIC PROFILE AS PREDICTOR OF RELAPSE IN RADICALLY RESECTED COLORECTAL CANCER 158
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management 156
Medical treatment for cholangiocarcinoma 156
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target 153
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival 151
Panitumumab for the treatment of metastatic colorectal cancer: A review 150
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. 149
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 146
Clinical evidence for three distinct gastric cancer subtypes: time for a new approach. 145
Trattamento del carcinoma del pancreas. Attualità e prospettive 145
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management. 143
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 142
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. 140
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 138
Doses of capecitabine and oral vinorelbine are not relevant for efficacy in breast cancer patients: an analysis of dose intensity. 137
ASSOCIAZIONE TRA STATO MUTAZIONALE DI KRAS E PATTERN DI ESPRESSIONE GENETICA NEL CARCINOMA DEL PANCREAS 135
Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer, from classical to innovation. 134
Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma 133
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 132
Role of β4 integrin in HER-3-negative, K-RAS wild-type metastatic colorectal tumors receiving cetuximab. 129
The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for advanced renal cell carcinoma patients receiving first-line sunitinib 126
Selecting the best treatment for an individual patient. 121
Palliative treatment 120
The challenge of targeted therapies for gastric cancer patients: The beginning of a long journey 118
Yes-associated protein and immunosuppressive microenvironment in pancreatic cancer development: A new strategy to improve immunotherapy efficacy? 117
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 112
The Tower of Babel of liver metastases from colorectal cancer: Are we ready for one language? 111
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectives. 110
Predictive factors for sunitinib treatment response in advanced renal cell carcinoma: are we really making steps forward? 93
Sicurezza degli ESA: sopravvivenza e stimolazione recettoriale/progressione tumorale 81
Totale 7.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022360 0 94 6 8 5 29 17 23 17 54 29 78
2022/2023854 60 117 59 62 62 141 1 46 193 10 80 23
2023/2024501 74 8 45 61 69 131 5 20 3 8 10 67
2024/2025987 148 77 20 21 64 49 99 35 162 71 133 108
2025/20262.720 209 184 132 309 379 208 417 259 210 232 81 100
2026/2027146 88 58 0 0 0 0 0 0 0 0 0 0
Totale 7.267